Back to Search Start Over

TRIM39 is a poor prognostic factor for patients with estrogen receptorā€positive breast cancer and promotes cell cycle progression

Authors :
Takuya Ogura
Kotaro Azuma
Toshihiko Takeiwa
Junichiro Sato
Keiichi Kinowaki
Kazuhiro Ikeda
Hidetaka Kawabata
Satoshi Inoue
Source :
Pathology International. 72:96-106
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

Tripartite motif (TRIM) family proteins are involved in various biological processes and the pathophysiology of cancers. However, the roles of TRIM39, a TRIM family member, in breast cancer is not well-understood. Here, we performed immunohistochemical study of TRIM39 protein in clinical estrogen receptor-positive (ER

Details

ISSN :
14401827 and 13205463
Volume :
72
Database :
OpenAIRE
Journal :
Pathology International
Accession number :
edsair.doi.dedup.....f1f60bba1282528f6b84bd626119d609